Effect of Pharmacological treatment on cardiac biomarkers in patients with acute coronary syndrome of non–ST segment elevation with Type-2 diabetes

Journal Title: International Journal of Medical and Health Sciences - Year 2016, Vol 5, Issue 1

Abstract

Background: The acute coronary syndrome is a consequence of coronary artery disease. Creatine Kinase MB is a cardiac biochemical marker used in the diagnosis and risk stratification of patients. The diabetes is a pathology associated to acute coronary syndrome non–ST segment elevation that change the cardiac conditions, in this sense, our objective was to evaluate the modifications of cardiac biomarkers values in diabetic patients. Materials and methods: A retrospective study included 155 patients of both sexes, ages ranging from 31 to 92 years old, admitted to the coronary unit of the “Reina Fabiola” Clinic, Córdoba, Argentina was performed in the period 2014-2015. Body mass index, time consultation pain, plasmatic Creatine Kinase isoenzyme MB activity and Troponin I levels were measured. The patients were stratified into two groups: without cardiovascular risk pathologies (Control group), n = 7; and with only type II diabetes, n = 64 treated with therapeutic doses of metformin (n= 37), and glibenclamide plus glizipide (n= 27). Results: cTnI levels were lower in both pharmacological treatments at 12 hrs when the values in control reach the highest. Similarly, CK-MB activity was lower at 8 hrs in both treatments; however at 12 hrs these values were lower only with metformin but not in glibenclamide plus glizipide treatment. These results could be showing an interaction between diabetes and pharmacological treatment upon the biomarkers values. Conclusion: The use of hypoglycemic drugs and the glycometabolic state are conditions that could modify CK-MB and cTnI release/clearance balance at 8 and 12 hrs after admission to the coronary unit.

Authors and Affiliations

Agustín N. JOISON, Gustavo BAIARDI

Keywords

Related Articles

Rare Case of Neck Swelling In An Adult

Cystic lymphangioma is rare congenital malformation commonly seen in children. Its occurrence in adults is uncommon with very scarce reports in the literature. Cysticlymphangioma mainly seen in infants or children youn...

Evaluation of Patient Satisfaction in Oral And Dental Health Centers

Introduction: The study was conducted in order to determine patient satisfaction in Oral and Dental Health Centers (ODHC) and to investigate the effects of sociodemographic variables on patient satisfaction. Materials a...

Antioxidants and Serum Uric Acid levels in Post-Stroke Cases

Background: Measurement of antioxidants and serum uric acid in post-stroke cases is very important because they may play a role in the prevention of stroke and its deleterious effects as they scavenge free radicals and...

Knowledge of Mothers regarding Breastfeeding related Problems in Peri urban Area of Aligarh: A Behaviour Change Communication Intervention Study

Background: Breastfeeding is simply the cheapest and healthiest way to feed a baby and is one of the oldest practices, recommended in the ancient Hindu scriptures, Holy Quran and Biblical records. Materials & Methods:...

Understanding Sleep: A Paradigm Shift

Sleep has fascinated since time immorial people across the spectrum of society and is continued even to the present day. It was considered as a passive phenomenon which rejuvenates the whole organism. However, a great...

Download PDF file
  • EP ID EP39941
  • DOI -
  • Views 250
  • Downloads 0

How To Cite

Agustín N. JOISON, Gustavo BAIARDI (2016). Effect of Pharmacological treatment on cardiac biomarkers in patients with acute coronary syndrome of non–ST segment elevation with Type-2 diabetes. International Journal of Medical and Health Sciences, 5(1), -. https://europub.co.uk/articles/-A-39941